Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer (Q28181638)
Jump to navigation
Jump to search
scientific article (publication date: February 2003)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer |
scientific article (publication date: February 2003) |
Statements
Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer (English)
0 references
February 2003
0 references
26
0 references
1
0 references
44-8
0 references